Mystery as UK Herceptin Decision Goes to Appeal Stage
NICE has received an appeal against its recent decision to approve the use of herceptin or trastuzumab as adjuvant therapy for early stage breast cancer.
NICE are duty bound to listen to any appeal that is raised against any drug decision that it makes.
This will leave many breast cancer patients on edge as they wait to hear confirmation of the appeals decision about herceptin use in the UK.
The appeal hearing will be held on 26th July in London
It is not known who has launched the appeal - but presumably they intend to try to stop the use of herceptin in the UK for early stage breast cancer.
Members of the public and the press may request to attend the hearing.
Read about this herceptin appeal case on the NICE website
Gordon
You can read more about herceptin for breast cancer here
Posts
Subscribe To Our Podcast
Ask Marjory or Gordon a Question ...
Ask Us A Question
Marjory
Pages
Help Us Help Others
Gordon
Invite your friends to visit this site
Spread the word ....
2 comments:
What's up with that? Any idea on the rationale behind this appeal? Some findings? Some profit motive? Hmmm. Here on the east coast US, herceptin seems to be pretty well accepted for her2 positive tumors. And I, for one, am going to be glad to get it.
Hang in there Marjory and Gordon, it appears that the PCT which appealed is still treating women with herceptin and according to the latest news "gearing up" to implement the guideline in October 06. See
http://www.inpharm.com/External/InpH/1,2580,1-4-0-0-inp_intelligence_news--460464,00.html
Keep up the good work. And think of us in NZ where PHARMAC, our equivalent of NICE, doesn't want to fund herceptin for women with early breast cancer because the data apparently "isn't clear" and it's too expensive. Kiwi Claire
Post a Comment